Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HUMA - Humacyte Inc

IEX Last Trade
6.05
-0.100   -1.653%

Share volume: 4,186,511
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$6.15
-0.10
-1.63%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 0%
Dept financing 14%
Liquidity 75%
Performance 11%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-13.94%
1 Month
-26.22%
3 Months
-33.52%
6 Months
37.50%
1 Year
52.39%
2 Year
54.34%
Key data
Stock price
$6.05
P/E Ratio 
-8.14
DAY RANGE
N/A - N/A
EPS 
-$0.86
52 WEEK RANGE
$1.96 - $9.97
52 WEEK CHANGE
$0.50
MARKET CAP 
722.074 M
YIELD 
N/A
SHARES OUTSTANDING 
119.351 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.61
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,344,127
AVERAGE 30 VOLUME 
$3,045,270
Company detail
CEO:
Region: US
Website: humacyte.com
Employees: 167
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

biotechnology company

Recent news